[Skip to Content]
[Skip to Content Landing]
Views 244
Citations 0
Capitol Health Call
March 10, 2015

Outdated Regulatory Processes Delay New Treatments, Senators Say

Author Affiliations

Copyright 2015 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.

JAMA. 2015;313(10):1004. doi:10.1001/jama.2015.0940

The United States’ global edge in medical innovation is slipping because the discovery and development process takes too much time and money, according to a report released January 29 by Sen Lamar Alexander (R, Tenn) and Sen Richard Burr (R, NC) (http://1.usa.gov/162Tm36).

One of the main reasons for the delay in getting treatments to patients is an overburdened FDA that can’t keep up with the fast pace of biomedical innovation, Alexander and Burr said in the report.